Statistics

TCRex currently provides prediction models for 51 different epitopes including 45 viral and 6 cancer epitopes. Performance metrics of these prediction models for the latest model version (i.e. version 2026-03-31) are shown in the tables below.

Cancer Epitope Version Nr. of sequences Balanced accuracy AUROC Average precision
Melanoma AMFWSVPTV 2026-03-31 82 0.59 ± 0.04 0.78 ± 0.04 0.48 ± 0.12
Melanoma EAAGIGILTV 2026-03-31 266 0.69 ± 0.03 0.9 ± 0.01 0.74 ± 0.01
Melanoma ELAGIGILTV 2026-03-31 1035 0.54 ± 0.0 0.72 ± 0.01 0.37 ± 0.03
Melanoma FLYNLLTRV 2026-03-31 61 0.63 ± 0.08 0.87 ± 0.03 0.59 ± 0.1
Multiple Myeloma LLLGIGILV 2026-03-31 233 0.58 ± 0.01 0.77 ± 0.04 0.44 ± 0.06
Tumor associated antigen (WT1) VLDFAPPGA 2026-03-31 1262 0.56 ± 0.01 0.8 ± 0.02 0.49 ± 0.03
Viral Epitope Version Nr. of sequences Balanced accuracy AUROC Average precision
HCV ARMILMTHF 2026-03-31 66 0.74 ± 0.07 0.86 ± 0.08 0.69 ± 0.12
HCV ATDALMTGY 2026-03-31 177 0.75 ± 0.03 0.91 ± 0.04 0.77 ± 0.06
HCV CINGVCWTV 2026-03-31 131 0.53 ± 0.03 0.75 ± 0.06 0.37 ± 0.11
HIV EIYKRWII 2026-03-31 185 0.65 ± 0.02 0.75 ± 0.06 0.52 ± 0.04
EBV EPLPQGQLTAY 2026-03-31 36 0.64 ± 0.08 0.91 ± 0.06 0.68 ± 0.18
HIV FLKEKGGL 2026-03-31 156 0.6 ± 0.03 0.76 ± 0.06 0.48 ± 0.1
HIV FPRPWLHGL 2026-03-31 120 0.81 ± 0.02 0.93 ± 0.02 0.83 ± 0.03
HIV FRDYVDRFYKTLRAEQASQE 2026-03-31 367 0.87 ± 0.02 1.0 ± 0.0 0.96 ± 0.01
Influenza GILGFVFTL 2026-03-31 3107 0.68 ± 0.01 0.81 ± 0.02 0.59 ± 0.02
EBV GLCTLVAML 2026-03-31 1208 0.66 ± 0.01 0.82 ± 0.02 0.59 ± 0.0
DENV2 GTSGSPIIDK 2026-03-31 60 0.61 ± 0.06 0.74 ± 0.08 0.49 ± 0.04
DENV3/4 GTSGSPIINR 2026-03-31 158 0.73 ± 0.02 0.86 ± 0.03 0.75 ± 0.03
DENV1 GTSGSPIVNR 2026-03-31 165 0.75 ± 0.05 0.88 ± 0.04 0.76 ± 0.06
HIV HPKVSSEVHI 2026-03-31 75 0.69 ± 0.07 0.87 ± 0.08 0.7 ± 0.16
EBV HPVGEADYFEY 2026-03-31 32 0.72 ± 0.08 0.86 ± 0.08 0.68 ± 0.13
HCV HSKKKCDEL 2026-03-31 45 0.77 ± 0.09 0.99 ± 0.01 0.93 ± 0.03
HIV IIKDYGKQM 2026-03-31 54 0.81 ± 0.07 0.95 ± 0.04 0.84 ± 0.07
CMV IPSINVHHY 2026-03-31 85 0.7 ± 0.02 0.84 ± 0.04 0.66 ± 0.06
HIV ISPRTLNAW 2026-03-31 58 0.61 ± 0.06 0.84 ± 0.03 0.6 ± 0.12
EBV IVTDFSVIK 2026-03-31 46 0.6 ± 0.05 0.83 ± 0.04 0.53 ± 0.05
HIV KAFSPEVIPMF 2026-03-31 210 0.73 ± 0.02 0.9 ± 0.01 0.71 ± 0.03
HCV KLVALGINAV 2026-03-31 65 0.62 ± 0.05 0.73 ± 0.08 0.51 ± 0.14
HIV KRWIILGLNK 2026-03-31 396 0.65 ± 0.02 0.85 ± 0.04 0.64 ± 0.08
HIV KRWIIMGLNK 2026-03-31 75 0.69 ± 0.05 0.85 ± 0.09 0.73 ± 0.12
YellowFeverVirus LLWNGPMAV 2026-03-31 474 0.66 ± 0.01 0.79 ± 0.01 0.53 ± 0.03
HIV LPPIVAKEI 2026-03-31 62 0.79 ± 0.04 0.9 ± 0.05 0.78 ± 0.06
Influenza LPRRSGAAGA 2026-03-31 2137 0.54 ± 0.01 0.84 ± 0.01 0.4 ± 0.02
CMV NLVPMVATV 2026-03-31 4812 0.56 ± 0.0 0.72 ± 0.01 0.39 ± 0.01
Influenza PKYVKQNTLKLAT 2026-03-31 292 0.52 ± 0.01 0.72 ± 0.02 0.36 ± 0.05
CMV QIKVRVKMV 2026-03-31 36 0.5 ± 0.0 0.79 ± 0.05 0.4 ± 0.09
HIV QVPLRPMTYK 2026-03-31 48 0.64 ± 0.04 0.77 ± 0.11 0.51 ± 0.16
CMV QYDPVAALF 2026-03-31 41 0.7 ± 0.06 0.82 ± 0.06 0.6 ± 0.06
EBV RAKFKQLL 2026-03-31 262 0.65 ± 0.02 0.89 ± 0.01 0.69 ± 0.04
HIV RFYKTLRAEQASQ 2026-03-31 210 0.9 ± 0.03 0.99 ± 0.0 0.96 ± 0.01
HIV RLRPGGKKK 2026-03-31 31 0.73 ± 0.06 0.89 ± 0.09 0.73 ± 0.2
HSV2 RPRGEVRFL 2026-03-31 63 0.77 ± 0.04 0.92 ± 0.05 0.84 ± 0.08
HIV RYPLTFGWCF 2026-03-31 30 0.52 ± 0.03 0.72 ± 0.13 0.42 ± 0.12
HTLV1 SFHSLHLLF 2026-03-31 131 0.68 ± 0.03 0.81 ± 0.08 0.63 ± 0.08
HIV TPGPGVRYPL 2026-03-31 86 0.68 ± 0.04 0.88 ± 0.03 0.74 ± 0.07
HIV TPQDLNTML 2026-03-31 159 0.81 ± 0.02 0.94 ± 0.04 0.87 ± 0.06
CMV TPRVTGGGAM 2026-03-31 258 0.7 ± 0.02 0.88 ± 0.03 0.75 ± 0.04
CMV VTEHDTLLY 2026-03-31 277 0.54 ± 0.0 0.78 ± 0.02 0.39 ± 0.04
SARS-CoV-2 YLQPRTFLL 2026-03-31 315 0.91 ± 0.01 0.97 ± 0.01 0.92 ± 0.01
CMV YSEHPTFTSQY 2026-03-31 74 0.59 ± 0.06 0.93 ± 0.04 0.71 ± 0.06
EBV YVLDHLIVV 2026-03-31 103 0.52 ± 0.02 0.76 ± 0.07 0.44 ± 0.09